Home › Funds › Pivotal bioVenture Partners Investment Advisor LLC › BIOA
Pivotal bioVenture Partners Investment Advisor LLC position in BIOA
BIOAGE LABS INC · Health Care
Pivotal bioVenture Partners Investment Advisor LLC reported holding 653,374 shares of BIOA (BIOAGE LABS INC) in its Q3 2026 13F filing — a position valued at US$4.6M, representing 1.89% of its reported portfolio and ranking #13 among its reported holdings. Pivotal bioVenture Partners Investment Advisor LLC has disclosed BIOA holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Pivotal bioVenture Partners Investment Advisor LLC's BIOA position evolved
Pivotal bioVenture Partners Investment Advisor LLC first disclosed a stake in BIOA in Q3 2024 at 527,647 shares (US$11.0M). The position peaked in Q2 2026 at 653,374 shares, worth US$16.0M. Across 9 filings, Pivotal bioVenture Partners Investment Advisor LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 7 time(s). The most recent filing (Q3 2026) shows 653,374 shares valued at US$4.6M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 527.65K | $10.98M | New |
| Q4 2024 | 653.37K | $3.78M | Add |
| Q1 2025 | 653.37K | $2.46M | Hold |
| Q2 2025 | 653.37K | $2.70M | Hold |
| Q3 2025 | 653.37K | $3.84M | Hold |
| Q4 2025 | 653.37K | $8.64M | Hold |
| Q1 2026 | 653.37K | $11.43M | Hold |
| Q2 2026 | 653.37K | $16.01M | Hold |
| Q3 2026 | 653.37K | $4.63M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BIOA and 13F data
BIOA (BIOAGE LABS INC) is a Health Care company. 61 other funds we track also report a position in BIOA — the largest reported positions include a16z Capital Management, L.L.C. (US$79.2M), Cormorant Asset Management, LP (US$58.6M), Sofinnova Investments, Inc. (US$56.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BIOA
- a16z Capital Management, L.L.C. 3.23M sh · $79.24M · Q2 2026
- Cormorant Asset Management, LP 2.39M sh · $58.59M · Q2 2026
- Sofinnova Investments, Inc. 2.29M sh · $56.22M · Q2 2026
- Octagon Capital Advisors LP 1.75M sh · $42.84M · Q2 2026
- RA CAPITAL MANAGEMENT, L.P. 1.67M sh · $40.97M · Q2 2026
- MPM BioImpact LLC 1.67M sh · $40.87M · Q2 2026
- BRAIDWELL LP 1.03M sh · $25.32M · Q2 2026
- STEMPOINT CAPITAL LP 464.17K sh · $11.38M · Q2 2026
- Comprehensive Financial Management LLC 271.84K sh · $6.66M · Q2 2026
- Sands Capital Alternatives, LLC 786.35K sh · $5.58M · Q3 2026
- SPHERA FUNDS MANAGEMENT LTD. 213.67K sh · $5.24M · Q2 2026
- Ikarian Capital, LLC 200.00K sh · $4.90M · Q2 2026
More on Pivotal bioVenture Partners Investment Advisor LLC
FAQ
How long has Pivotal bioVenture Partners Investment Advisor LLC held BIOA?
Pivotal bioVenture Partners Investment Advisor LLC has disclosed BIOA holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
What is Pivotal bioVenture Partners Investment Advisor LLC's current position in BIOA?
As of Q3 2026, Pivotal bioVenture Partners Investment Advisor LLC holds 653.37K shares of BIOA (BIOAGE LABS INC), valued at $4.63M, representing 1.89% of its reported portfolio and ranking #13.
Has Pivotal bioVenture Partners Investment Advisor LLC been buying or selling BIOA?
In the latest 13F filing (Q3 2026), Pivotal bioVenture Partners Investment Advisor LLC held unchanged its position in BIOA. The position peaked in Q2 2026 at 653.37K shares.
Which other funds hold BIOA?
Other major institutional holders of BIOA include a16z Capital Management, L.L.C., Cormorant Asset Management, LP, Sofinnova Investments, Inc., among 61 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.